Countdown Until IAP 2022

IAP_Seal_blue-with-white-space

The International Academy of Pathology is the largest professional body of pathologists worldwide and the 2022 World Congress in Sydney will see one of the largest exchanges of educational advancements in the world.

On behalf of the Local Organising Committee for the XXXIV International Congress of the International Academy of Pathology (IAP) and the host the Australasian Division of the International Academy of Pathology we are delighted to welcome you all to IAP 2022, to be held in Sydney, Australia, from 11-13 October 2022 virtually and in-person from 14-15 October 2022.

The theme of IAP 2022 is “Bridge to a Cure”. Discover Australia and discover the innovation that lies where practical problems meet leading scientific developments.  IAP 2022 will focus on the application of theory and the discovery that comes when world-class minds are focussed on all specialities of pathology.  Our Congress Program and sessions reflect this emphasis on science and is designed to trigger collaboration, innovation and discovery from a diverse group of participants.

Australia is a unique land and a diverse country in every way imaginable – in culture, population, climate, geography and history.  The identity of all Australians, but especially our Indigenous Australians, is shaped by our relationship with the natural environment.  Sydney, as host city, has much to offer our delegates, with a diverse range of attractions.

The Australasian Division of the Academy, the host society for IAP 2022, truly embodies the diversity of our profession, welcoming pathologists and industry, who come together to help advance the profession in Australia and beyond.

IAP 2022, Sydney, is an opportunity for delegates to make that once in a lifetime trip downunder and discover why there’s nothing and nowhere quite like Australia.

We have created a dynamic hybrid offering, acknowledging the times we are in, and whether you are able to join us virtually or on-person, you can be assured of a benchmark IAP Congress experience.

Professor Jane Dahlstrom OAM

Congress Co-President
Co-Chair of Scientific Organising Committee

Professor Richard Scolyer AO

Congress Co-President
Co-Chair of Scientific Organising Committee

Associate Professor Fiona Maclean

Australasian Division President

Sydney to host the next IAP in 2022

In October 2022 the Australasian Division invites the world to experience the latest developments in pathology by hosting the XXXIV International Congress of the International Academy of Pathology.

The Local Organising Committee has already secured world-class speakers and is planning for a memorable experience in Sydney. Be sure to save the dates of 11-15 October 2022 where it is expected that the largest gathering of pathologists will share science and be provided an unparalleled opportunity to engage informally with each other. The local hosts will also showcase the beauty of Sydney and Australia and display Australian hospitality at its best.

This Congress is sure to be a must-attend event for all.

To keep up to date with IAP 2022,

pathology-w
Asset 7

Meet the Committee

The IAP 2022 Committee are honoured to be organising the Congress on behalf of our global pathology community, led by Congress Chair Professor Richard Scolyer.

Asset 10

Partner with IAP 2022

Partnering with IAP 2022 is your opportunity to connect and engage with the world’s leading professionals in this sector. Our goal is to create dynamic networking and professional growth opportunities for you.

IAP 2022 Sydney Confirmed Plenary Speakers

Prof. Tan Puay Hoon

Prof. Tan Puay Hoon

Senior Consultant Histopathologist and Chairman, Division of Pathology, Singapore General Hospital, Singapore

Prof. Tan Puay Hoon

Prof. Tan Puay Hoon, Chairman, Division of Pathology and Senior Consultant, Department of Anatomical Pathology at Singapore General Hospital (SGH) enjoys the rare distinction of being the first woman from Singapore to be a volume editor of the World Health Organisation’s classification of Tumours of the Breast.

In addition Prof. Tan Puay Hoon has can also be credited with being the first Chairman of the Division of Pathology at one of Singapore’s leading hospitals.

She has active interests in breast, urologic and renal pathology, and was a Volume Editor of the 2012 WHO classification of Tumours of the Breast.

Prof. Jason Hornick

Prof. Jason Hornick

Director of Surgical Pathology, and Director of the Immunohistochemistry Laboratory at Brigham and Women’s Hospital, Professor of Pathology at Harvard Medical School, USA

Prof. Jason Hornick

Prof. Jason Hornick trained as a resident in Anatomic Pathology and pursued subspecialty fellowships in soft tissue pathology and gastrointestinal pathology at Brigham and Women’s Hospital, where he is now the Director of Surgical Pathology and Director of Immunohistochemistry. He is a Professor of Pathology at Harvard Medical School and a consultant at the Dana Farber Cancer Institute.

Prof. Hornick is Chair of the USCAP Education Committee, past Chair of the USCAP Abstract Review Board and Assignment Committee, and past Chair of the Immunohistochemistry Committee for the CAP.

She has active interests in breast, urologic and renal pathology, and was a Volume Editor of the 2012 WHO classification of Tumours of the Breast.

Prof. Barry Marshall AC

Prof. Barry Marshall AC

Nobel Prize Laureate in Physiology or Medicine, Professor of Clinical Microbiology at the University of Western Australia, Australia

Prof. Barry Marshall AC

Prof. Marshall has received many honors for his work on Helicobacter pylori, most notably they include, the Nobel Prize for Medicine or Physiology in 2005, The William Beaumont Prize in 2006 (American Gastroenterology Association), in 1995 the Albert Lasker Award (Albert & Mary Lasker Foundation), and in 1998 the Dr. A. H. Heineken Prize for Medicine (The Alfred Heineken Foundation, Amsterdam).

In the past few years Prof. Marshall’s laboratory has developed enhanced methods for non-invasive studies on the molecular epidemiology of H. pylori, notably rapid breath test methods and retrieval of the organism (and culture) from a swallowed string.

Prof. Elizabeth Murchison

Prof. Elizabeth Murchison

Group Leader, Reader in Comparative Oncology and Genetics, Wellcome Trust Investigator, University of Cambridge, Department of Veterinary Medicine, United Kingdom

Prof. Elizabeth Murchison

Prof. Elizabeth Murchison is Reader in Comparative Oncology and Genetics at the University of Cambridge, Department of Veterinary Medicine. Her research group works on transmissible cancers in dogs and Tasmanian devils.

Prof. Murchison grew up in Tasmania and performed her undergraduate studies in genetics and biochemistry at the University of Melbourne. In 2009, she was awarded an NHMRC Overseas Biomedical Fellowship to travel to the Wellcome Trust Sanger Institute, UK, where she was involved in sequencing the Tasmanian devil genome as well as genetic analysis of Tasmanian devil facial tumour disease (DFTD) and CTVT. Prof. Murchison moved to the University of Cambridge, Department of Veterinary Medicine in 2013.

Join the Newsletter

If you would like to receive updates and information on the progress of IAP 2022 which will be held in Sydney, please join the mailing list by filling in details and select your interest for the conference.